Clinical Trials Sponsored by French cancer Institute INCa

Total 1344 results

Kentuckiana Cancer Institute
Eisai Inc.

Unknown

A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, Followed By Dose Dense Therapy With Temozolomide For Newly Diagnosed Malignant High Grade Glioma (KARE003)

Glioma

United States
Institut Bergonié
Merck Sharp & Dohme LLC; National Cancer Institute, France; Transgene; Fondation...

Recruiting

A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX) (METROmaJX)

Breast Cancer | Soft-tissue Sarcoma | Solid Tumors

France
Institut National de Recherche pour l'Agriculture...
National Cancer Institute, France

Completed

An Interventional Study to Reduce Social Disparities in Diet Quality in the Northern Districts of Marseille (Opticourses)

Nutritional Quality of Food Purchases
Dana-Farber Cancer Institute
National Cancer Institute (NCI); Eisai Inc.

Completed

Effect of Perampanel on Peritumoral Hyperexcitability in HGG

Seizures | Surgery | Glioma, Malignant

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI); Genentech, Inc.

Completed

Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
Seagen Inc.; Hôpitaux Universitaires Henri Mondor, France

Completed

Brentuximab Vedotin (SGN-35) in Transplant Eligible Patients With Relapsed or Refractory Hodgkin Lymphoma

Hodgkin's Lymphoma

United States
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute, France; Merck Serono International SA; Ligue contre...

Completed

Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer (ELAN-UNFIT)

Head Neck Cancer Squamous Cell Recurrent

France
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; National Cancer Institute, France

Not yet recruiting

Personalized Medicine in Early Stage Colorectal Cancer: Organ Preservation and Immune Benefit (COLOSAVE)

Colorectal Cancer

France
University Hospital, Bordeaux
National Cancer Institute, France; Ministry for Health and Solidarity, France

Completed

Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric Tumors (PEC-Hem)

Hemangioma | PEComa

France
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; National Cancer Institute, France

Completed

Smoking Cessation for Patients With Acute Coronary Syndrome (ACS) (PATPAC)

Smoking | Acute Coronary Syndrome

France
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; National Cancer Institute, France

Terminated

Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE) (PROVE)

Venous Thromboembolism | Lung Neoplasm

France
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; National Cancer Institute, France

Unknown

Anti Xa Activity in Cancer Patients Receiving Low-molecular-weight Heparin for Venous Thromboembolism (aXa)

Neoplasms | Venous Thromboembolism

France
Assistance Publique - Hôpitaux de Paris
National Cancer Institute, France

Not yet recruiting

Evaluation of a Multimodal Strategy for Early Diagnosis of Men at High Genetic Risk of Prostate Cancer (HRPCa-II) (HRPCa-II)

Prostate Cancer
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Montefiore Medical Center; American Cancer Society...

Completed

Interindividual Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Bone Marrow Transplantation Patients

Neoplasms

United States
Assistance Publique - Hôpitaux de Paris
National Cancer Institute, France

Recruiting

Positioning of Molecular Markers in Clinical Routine for the Management of Patients With Adrenal Cancers/Tumors (COMETE-CARE) (COMETE-CARE)

Cancer | Adrenal

France
UNICANCER
AstraZeneca; National Cancer Institute, France; Pierre Fabre Laboratories

Active, not recruiting

Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours (MOVIE)

Breast Cancer | Head and Neck Cancer | Prostate Cancer | Cervix Cancer | Advanced Solid Tumours

France
Assistance Publique - Hôpitaux de Paris
National Cancer Institute, France

Completed

Elderly CAncer Patient: Qualitative and Quantitative Factors of Inclusion Failure in Clinical Trials (Quali-SAGE)

Cancer | Elderly | Ethnographic Interview | Social Representation of Being Aged | Reasons of Non-participation in Clinical Trials | Qualitative Method

France
Assistance Publique - Hôpitaux de Paris
National Cancer Institute, France

Unknown

Financial Incentive for Smoking Cessation in Pregnancy (FISCP)

Smoking | Pregnancy

France
Centre Hospitalier Universitaire de Besancon
National Cancer Institute, France

Completed

Allogenic Immunotherapy Based on Natural Killer (NK) Cell Adoptive Transfer in Metastatic Gastrointestinal Carcinoma Treated With Cetuximab (NK-EGFR01)

Gastrointestinal Metastatic Cancer

France
Centre Leon Berard
National Cancer Institute, France; Fondation ARC

Completed

Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive (PIK-ORL)

Head and Neck Neoplasms | Neoplasm Metastasis | Progressive Disease | Recurrent Disease

France
Centre Oscar Lambret
Novartis Pharmaceuticals; National Cancer Institute, France

Completed

Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic Neuroblastoma (MIITOP)

Neuroblastoma

France
Centre Hospitalier Universitaire de Nice
National Cancer Institute, France

Completed

GENSARC 2008 : Medical Economic Evaluation of the Molecular Detection by FISH (Fluorescent in Situ Hybridization) and by PCR (Polymerase Chain Reaction) of Sarcomas Specific Translocations and Amplifications . (GENSARC)

Sarcoma

France
University Hospital, Toulouse
Institut National de la Santé Et de la Recherche Médicale, France; National...

Recruiting

Understanding and Overcoming the Early Adaptive Resistance to EGFR Tyrosine-kinase Inhibitors in Lung Cancer Patients (LUNG-RESIST)

Lung Cancer, Nonsmall Cell

France
Centre Leon Berard
Institut National de la Santé Et de la Recherche Médicale, France; National...

Completed

A Case-control Study to Assess the Association Between Environmental, Domestic and Occupational Exposures and the Risk of Testicular Germ Cell Tumor (TESTIS)

Testicular Germ Cell Tumor

France
Dana-Farber Cancer Institute
National Cancer Institute (NCI); Genentech, Inc.

Completed

Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer

Head and Neck Cancer

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); Affini-T Therapeutics, Inc.

Active, not recruiting

Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer

Other Skin

United States
H. Lee Moffitt Cancer Center and Research Institute
American Cancer Society, Inc.

Active, not recruiting

Effect of Prolonged Nightly Fasting on Immunotherapy Outcomes in HNSCC - Role of Gut Microbiome

Head and Neck Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
American Cancer Society, Inc.

Completed

Increasing Access to Colorectal Cancer Testing (IACCT) for Blacks (IACCT)

Colorectal Cancer | Colorectal Carcinoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); American Stem Cell, Inc.

Completed

Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

Lymphoma | Leukemia | Transplantation Infection | Blood And Marrow Transplantation | Transplantation, Bone Marrow

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); Astex Pharmaceuticals, Inc.

Completed

Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide

Unspecified Adult Solid Tumor, Protocol Specific

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI); Pinnacle Biologics Inc.; Simphotek Inc.

Recruiting

Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer

Small Cell Lung Carcinoma | Stage III Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer AJCC v8 | Non-Small Cell Lung Carcinoma | Locally Advanced Lung Carcinoma

United States
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI); Arcascope, Inc

Completed

Lighting Intervention for Cancer-related Fatigue

Breast Cancer | Fatigue | Prostate Cancer | Hematologic Malignancy | Survivorship

United States
H. Lee Moffitt Cancer Center and Research Institute
American Cancer Society, Inc.

Completed

Stress Management Training for Latinas Receiving Chemotherapy

Cancer | Stress

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Astex Pharmaceuticals, Inc.

Completed

Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia

Lymphoma | Leukemia

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Miltenyi Biotec, Inc.

Completed

Hematopoietic Stem Cell Transplantation for Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using Total Body Irradiation, Cyclophosphamide and Fludarabine

Fanconi Anemia

United States
Centre Jean Perrin
National Cancer Institute, France; ARC Foundation for Cancer Research

Completed

Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma (GLYRad)

Adult Glioblastoma

France
Centre Francois Baclesse
National Cancer Institute, France; ARC Foundation for Cancer Research

Terminated

A Multicenter Trial Assessing the Efficacy and Safety of tamOxifen Plus LY2228820 in Advanced or Metastatic Breast Cancer Progressing on aromatasE Inhibitors (OLYMPE)

Metastatic Breast Cancer | Postmenopausal

France
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); Pfizer; Oncovir, Inc.

Completed

Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100

Melanoma

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); Sanofi; Genentech, Inc.

Completed

Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma

Ovarian Cancer | Fallopian Tube Cancer | Malignant Tumor of Peritoneum

United States
Association pour le Dépistage Organisé des Cancers...
National Cancer Institute, France

Unknown

Colorectal Cancer Screening French Organizations for the Follow-up After Colonoscopy (Tempo-colo)

Colorectal Cancer

France
Université de Caen Normandie
National Cancer Institute, France; Regional health agency, Normandy France; Pink... and other collaborators

Enrolling by invitation

A Randomized Cluster Trial to Evaluate a Mobile Mammography Unit in Breast Cancer Screening in France (Mammobile) (Mammobile)

Breast Cancer

France
Known Medicine, Inc.
M.D. Anderson Cancer Center; Mayo Clinic; Duke Cancer Institute

Recruiting

KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models

Cancer | Effects of Chemotherapy | Predictive Cancer Model

United States
H. Lee Moffitt Cancer Center and Research Institute
American Cancer Society, Inc.

Recruiting

Improving Sleep in BMT Survivors

Sleep Disorder | Sleep Disturbance

United States
Spectrum Pharmaceuticals, Inc
National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center

Completed

10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma

Lymphoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Astellas Pharma US, Inc.

Completed

Erlotinib Prevention of Oral Cancer (EPOC)

Oral Cancer

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); Horizon Pharma USA, Inc.

Terminated

Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma

Myxoid Liposarcoma | Synovial Sarcoma | Round Cell Liposarcoma

United States
H. Lee Moffitt Cancer Center and Research Institute
American Cancer Society, Inc.

Completed

Support for People Undergoing Chemotherapy

Quality of Life | Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
American Cancer Society, Inc.

Terminated

Evaluation of Image-guided Brushing of Pancreatic Cyst Wall in Diagnosis of Cystic Pancreatic Tumors

Pancreatic Tumors

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.

Terminated

A Combination of Zarnestra With Velcade for Patients With Relapsed Multiple Myeloma

Multiple Myeloma

United States
National Cancer Institute (NCI)
Millennium Pharmaceuticals, Inc.

Withdrawn

Phase II Study of Subcutaneous (SC) Bortezomib, Lenalidomide and Dexamethasone for Relapsed and/or Refractory Multiple Myeloma; Followed by SC Bortezomib Maintenance

Multiple Myeloma

Clinical Trials Sponsored by French cancer Institute INCa

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations